chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist and refers to a 60 year old male patient. The patient's concurrent conditions included esophageal cancer and high blood pressure. On 27-SEP-2016, the patient was subcutaneously (SQ) vaccinated with a 19.400units/0.65ml dose of ZOSTAVAX lot # M026876, expiration date 26-JUL-2017 (dose and anatomical location were not reported). On the same day, the patient was vaccinated with a dose of (unspecified) TDAP (manufacturer unknown) and influenza virus vaccine (unspecified) (manufacturer unknown). Other concomitant therapy included unknown chemotherapy drug. The pharmacist reported that the patient's A1C was a little low on that day (low 500 range) per the patient's nurse. The pharmacist reported that on that day, 27-SEP-2016, he was informed that the patient had esophageal cancer and was on chemotherapy after he had given the patient the ZOSTAVAX. The pharmacist reported that he notified the patient's doctor and provided consultation to the patient, which included referring the patient to his physician if he noticed fever or fatigue. As of 27-SEP-2016, the patient received the ZOSTAVAX and the outcome of receiving the vaccine as a cancer patient who received chemotherapy was reported as unknown. The causality between the event and ZOASTAVAX was not reported. Additional information has been requested.
Received the vaccine at 2:30 PM. Approximately at 2:50 I started feeling paresthesia of my left leg, approximately 1 to 2 hours later a progressed to my left arm. Around 8:00 PM it progressed to my right leg, right arm, torso and face. I subsequently took Aleve. No significant shortness of breath, or weakness noted. This morning paresthesia continues but less apparent. It feels more apparent in my left side. I can no longer feel it on my torso or face.
Profuse sweating, no fever, aching  throughout body starting at midnight.  Lasted until 9 a.m. on 2/16/21
A rash on her hand; This is a spontaneous report from a non-contactable consumer reported for a female patient (reporters Another friend). This is second report.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the reporter stated that another friend had a rash on her hand after the vaccine and says she did not see the rash since the friend wore a glove at the time, she visited her. The outcome was unknown for the event.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt recv vax on 10/3/96; in 12/96 pt exp pain in right hip &left knee consistent w/ arthritis; tx=Salindac.
MODERNA 7/18/22 PT CAME IN AND STATED SHE HAD REACTION TO MODERNA SHOT THAT SHE RECEIVED ON 7/13/2022.  LATER IN THE EVENING AFTER SHE RECEIVED THE SHOT, SHE HAD A PAIN IN HER LOWER BACK THAT RADIATED UP HER LEFT SIDE AND MADE HER HEART BEAT EXTREMELY RAPIDLY.  PT STATES THE SYMPTOMS WENT AWAY THE FOLLOWING DAY.
I had issues with my heart rate jumping up really fast the next day after the vaccine and would drop when I sat down but the real problem started with numbness in my feet. That traveled up with my hip making it difficult to walk. My legs were heavy. Over a few days it skipped my trunk and I woke up with numb hands and arms to elbows, couldn?t lift a coffee cup. That day it traveled to my shoulders and then to my head.  In  neck and head it was super heavy. That night I felt like a scanning sensation in my head from top to bottom twice. A had a few days of just mild numbness and tingling about 3 weeks out from the vaccine and now ever since (over 8 weeks) I have severe nerve pain in my extremities. It?s so severe I have to take gabapentin and that only takes the edge off. I was very active, eat right, exercise and now I?m miserable.
7-8 days after first dose of vaccine, my left arm, around the injection site was swollen, red, warm, and itchy.
It has been 10 days since my vaccine and I still have pain and itchiness at the injection sight.  the itchiness covers my entire deltoid.
flu like symptoms; swollen arm; sore arm; This spontaneous case was reported by a health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PERIPHERAL SWELLING (swollen arm) and PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Dec-2020, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PERIPHERAL SWELLING (swollen arm) and PAIN IN EXTREMITY (sore arm). On 30-Dec-2020, INFLUENZA LIKE ILLNESS (flu like symptoms), PERIPHERAL SWELLING (swollen arm) and PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medication provided no treatment given; Sender's Comments: Very limited information regarding the events has been provided at this time. No consent was provided to follow-up.' Because the temporal association is not clearly stated.
Fist dose  was / 2018 / second dose administrated March 18 2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 7Y359, expiry date 15th November 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date in 2018).   On 18th March 2021, the patient received the 2nd dose of Shingrix. On 18th March 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follow:  No vaccination date provided for the first dose. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. The patient had no known side effects. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
Numbness and tingling down left arm/hand. Tight, swollen neck muscle(s). Extremely high blood pressure, missing periods.
Migraine with aura with dose #2 (Of note, also had migraine with aura after dose #1 on 12/28/2020, 46 hours after receiving the vaccine)
developed a rash on one side of her body shortly after receiving ZOSTAVAX / Diagnosed the rash as Shingles; This spontaneous report was received from the patient's neighbor, referring to a 63 year old female patient. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were unknown by the reporter.  On an unknown date, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) to prevent shingles (strength, dose, route, frequency, lot# and expiration date were not reported).  On an unknown date, the patient developed a rash on one side of her body shortly after receiving Zoster Vaccine Live (ZOSTAVAX), subsequently, the patient sought medical attention and was diagnosed with Shingles (herpes zoster).  At the time of reporting, the outcome of shingles was unknown reported as "doing great now". The causality assessment between herpes zoster with Zoster Vaccine Live (ZOSTAVAX) was not provided.
About 15 hours after the vaccination, my feet were starting to get cold so I put on a pair of socks before going to bed.  Then 2 days after the vaccination I started to feel a swelling on the left side of my top lip, and it has grown to about a 2 mm size cold sore, as of today.
15 year old received Moderna 1st dose on accident; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna 1st dose on accident) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna 1st dose on accident). On 08-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna 1st dose on accident) had resolved.            No concomitant drug details were reported. No treatment details were reported.
had second shot on April 16th and same thing continued.Diarrhea; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (had second shot on April 16th and same thing continued.Diarrhea) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047821A and 033821A) for COVID-19 vaccination.     Concurrent medical conditions included Irritable bowel syndrome.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (had second shot on April 16th and same thing continued.Diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (had second shot on April 16th and same thing continued.Diarrhea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication was provided.
PATIENT STARTED HAVING DIFFICULTY BREATHING AND WHEEZING.  WE ELEVATED HER LEGS AND HAD HER STAY SEATED.  SHE WAS GIVEN AN ALBUTEROL INHALER AND USED 2 PUFFS IN WHICH IMMEDIATELY SHE FELT BETTER AND WAS ABLE TO BREATHE AGAIN.
30 min after receiving vaccine, pt stated she had nausea and vomiting.  pt was given medication to help with nausea.
Patient received the pharmacy 12/6 and called the pharmacy on 12/10 and stated that he has had throat swelling, coughing up blood, headaches, body aches, headaches, intermittent chest pain, and congestion. Informed patient to seek medical attention ASAP. Patient said he will if he has time.
Fever, NauseaVomiting, Site discomfort, chills Narrative:
pt recv varivax on 22FEB96;contracted varicella 14NOV96;
This case involves patient (unknown demographics) who experienced worst flu (influenza), after the patient received vaccine INFLUENZA VACCINE. The patient's past medical treatment, vaccination, concomitant medication and family history were not provided. It was unknown if the patient had any medical history, concomitant disease or risk factor. On an unknown date, the patient received a two in one shot. INFLUENZA VACCINE and ammonia shot produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination. On an unknown date, the patient developed a non-serious worst flu (influenza) and ammonia (unknown latency) following the administration of INFLUENZA VACCINE. It was reported that patient would never take any kind of shots again. Patient would trust the immune system God blessed me with. And if patient got the flu or coronavirus disease (COVID) or well. That life. God will sustain the patient. Screw the flu shot and all vaccinations. It was unknown if the patient experienced any additional symptoms/events. Medication details and reason for taking the medicine not provided. There were no lab data/results available. It was not reported if the patient received a corrective treatment. The event outcome was unknown for influenza. There will be no information available on the batch number for this case.
Patient didn't have an adverse event. Clinical Coordinator wants the pharmacist to fill out a VAERS because Fluvirin 2014-2015 with preservative was administered to a pregnant woman.
Left arm with knot 1-2 inches and samll red area about 1/2 inch.  Mom took child to Dr, no treatment required.
Left thigh 11 1/2 cm x 14cm redness, no pain, no induration.
Tinnitus  occurred after all three doses, increasing intensity with each dose.   It is extreme now and 24 hours a day, every day. I asked about this at vaccine site prior to booster dose and they denied any reports or relationship noted prior.  I was told I had to get the booster to maintain employment. I went to ENT a few months ago and he stated that the tinnitus was not from the vaccine and there was no treatment but to use a sound machine at night to sleep.  He said that some people get a little relief from hearing aids but did not feel I qualified for hearing aids.
cold like symptoms, nasal congestion, cough starting on 10/12/21, husband has also recently tested positive
pt recvd vax 28SEP92 & w/in 30 seconds, vomited & exp a vasovagal episode; recovered w/in 5 minutes;
Child monitored for 15 min after injection due to "gentamycin allergy" reported on form. Child states she feels short of breath. Child does no appear to be in distress. Lungs GA. Child reports improvement in condition and returned to class. School nurse and teachers aware of above and will continue to monitor.
nausea - 30-45 minutes shortly after injection 1/29/21 fatigue body aches - began shortly after injection, continuing but lessened  muscle spasms - from  2/2/21 to 2/3/21
Feels like he was about to pass out; White as ghost; Body ache; Fever; chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Feels like he was about to pass out), PALLOR (White as ghost), PAIN (Body ache), PYREXIA (Fever) and CHILLS (chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PRESYNCOPE (Feels like he was about to pass out), PALLOR (White as ghost), PAIN (Body ache), PYREXIA (Fever), CHILLS (chills) and ARTHRALGIA (Joint pain). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) for Adverse event, at a dose of 2 UNK. At the time of the report, PRESYNCOPE (Feels like he was about to pass out), PALLOR (White as ghost), PAIN (Body ache), PYREXIA (Fever), CHILLS (chills) and ARTHRALGIA (Joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.   Reporter did not allow further contact
Patient developed red pinpoint rash all over arms, feet, trunk within 15 minutes of vaccine which eventually spread from trunk up abdomen to chest and neck. Patient vitals remained stable and had no problem breathing but rash spread and injection site was itchy.  Patient was given benadryl cream at injection site and as rash spread, was given 25 mg oral benadryl.  After 30 min observation, no change in symptoms. Rash did stop spreading, remained constant over arms, hands, chest and abdomen, flank, and feet.  Did not extend to legs.
?Covid Arm? - injection site warm, raised, red/blotchy, and itchy.
rash over abdomen, itchy, thus far treating with antihistamines and topical steroids
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Relevant medical history and concurrent condition was reported as Heart.  Concurrent medical conditions included Allergy.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2022, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had resolved.            No concomitant medications were reported  No treatment medications were reported  Co-suspect was reported as COVID-19 Treatment with start date 6-MAY-2022 and stop date 10-MAY-2022. It was reported that the patient was taking any other medications or products within 2 weeks of starting COVID-19 treatment It was reported that Started pills. Felt well after 2 days. Became ill again with same symptoms congestion, cough, fatigue, chills sweating to lesser intensity 5 days after stopping pills.  Device Date was reported as 20-May-2022  Company comment- This spontaneous case concerns a 67-year-old male patient with no reported medical history, who experienced the unexpected non-serious adverse event of special interest COVID-19 which occurred at an unknown time with regards to the mRNA-1273 vaccination. Patient was started on pills which made him feel better after 2 days. He then felt ill again with the same symptoms of congestion, cough, fatigue, chills and sweating 5 days after stopping the medication. Outcome of the event was resolved at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 67-year-old male patient with no relevant medical history, who experienced the unexpected non-serious adverse event of special interest COVID-19 which occurred at an unknown time with regards to the mRNA-1273 vaccination. Patient was started on pills which made him feel better after 2 days. He then felt ill again with the same symptoms of congestion, cough, fatigue, chills and sweating 5 days after stopping the medication. Outcome of the event was resolved at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
COVID-19; COVID-19; vaccine brand other=Moderna, Vaccine dose number=1, vaccine dose number=2, vaccine brand=Pfizer / BioNTech; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Feb2021 as dose 2, single (Batch/Lot number: unknown) at the age of 44 years for covid-19 immunisation; covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 29Dec2020 as dose 1, single (Batch/Lot number: unknown) and on 19Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Migraine headache" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown", described as "vaccine brand other=Moderna, Vaccine dose number=1, vaccine dose number=2, vaccine brand=Pfizer / BioNTech". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course included that recurrence of covid sx 2-8 days after completion of Paxlovid 5 day course and full resolution of symptoms. recurrence symptoms include headache/ diarrhea/ body aches and fever.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective and COVID-19 cannot be ruled out.
Patient is a 41-year-old female who presents for evaluation of left arm injection site reaction. Patient states she had the hepatitis A vaccination injection given her left arm on 10/8/18. Patient states about 3 weeks after getting the injection, she noted a knot appear near injection site on her proximal left upper extremity. Patient states that the knot increased in size and became erythematous. Per patient, the area continued to swell and drained. States the drainage was a brownish/yellow malodorous drainage. Denies fever, chills, sweats. Rates pain 1/10. Denies any problems since it drained originally.
pityriasis rosea, small circular bumps and one large circular ring (resembled ring worm) under arm on left side of her torso. They covered her entire stomach, back and started going down her legs and arms.
Blood clots in both lungs; Feels really tired all the time; Joints hurt; This spontaneous case was reported by a patient and describes the occurrence of PULMONARY EMBOLISM (Blood clots in both lungs) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acid reflux (esophageal) and Retinal migraine. Concomitant products included RABEPRAZOLE SODIUM for Acid reflux (esophageal), METOPROLOL for Retinal migraine.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (Feels really tired all the time) and ARTHRALGIA (Joints hurt). On an unknown date, the patient experienced PULMONARY EMBOLISM (Blood clots in both lungs) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from 10-Apr-2021 to 15-Apr-2021 due to PULMONARY EMBOLISM. At the time of the report, PULMONARY EMBOLISM (Blood clots in both lungs) and ARTHRALGIA (Joints hurt) outcome was unknown and FATIGUE (Feels really tired all the time) had not resolved.            Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25 May 2021 contains no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Severe pain in the upper arm in which she received the vaccine which started 8 days after administration. Associated symptoms include numbness and tingling in the right 1st and 2nd digits. fingers also turned white. Color change and pain improved with a medrol dosepak but pain has recurred off steroids.
Pt. reported by phone call that the arm she received the flu shot hurt with movement. She seen a doctor around the end of November and was given an anti-inflamatory medication per pt. She said it continued to hurt so the doctor is giving her a steroid next.
It was reported that a 2 year old male pt received a TriHibit (a combination of Act-Hib and Tripedia) and a MMR (Merck) vaccination on 7/11/00 at 11:00. By that evening, the pt developed a lump the size of a tennis ball on his right lateral thigh with an erythema multiform type rash. The pt also developed hives that progressed to bruising and purpura on his chest, back and thighs. Treatment of Benadryl was given.